Core Insights - Illinois Tool Works Inc. (ITW) is a diversified industrial company with a market capitalization of $70 billion, serving various sectors including food equipment, welding, automotive OEM, construction, polymers and fluids, and specialty products [1] Performance Overview - Over the past 52 weeks, ITW shares have declined by 10.4%, underperforming the S&P 500 Index, which has gained 13.7% during the same period [2] - Year-to-date, ITW's stock is down 4.6%, while the S&P 500 has returned 13.4% [2] - ITW has also underperformed the Industrial Select Sector SPDR Fund (XLI), which has seen a 7.8% increase over the past 52 weeks and a 13.7% rise year-to-date [3] Earnings Report - On October 24, ITW's shares fell by 4.5% following a mixed Q3 earnings report, where EPS decreased by 28.1% year-over-year to $2.81, although it exceeded consensus estimates by 4.5% [3] - Operating revenue for the quarter was $4.1 billion, reflecting a 2.3% increase from the previous year, but it slightly missed analyst expectations, impacting investor confidence [3] Future Projections - For the current fiscal year ending in December, analysts project ITW's EPS to grow by 2.9% year-over-year to $10.44 [4] - ITW has a strong earnings surprise history, having exceeded consensus estimates in each of the last four quarters [4] Analyst Ratings - Among 17 analysts covering ITW, the consensus rating is a "Hold," with two "Strong Buy," ten "Hold," one "Moderate Sell," and four "Strong Sell" ratings [4] - Bank of America maintained a "Sell" rating on ITW with a price target of $220, while the mean price target is $261.47, indicating a 7.6% premium from current levels [6] - The highest price target from analysts is $287, suggesting an 18.1% potential upside from current levels [6]

Core Insights - Cboe Global Markets, Inc. (CBOE) is a prominent global exchange operator with a market cap of $27 billion, known for its VIX volatility index [1] Performance Summary - CBOE shares have increased by 28.5% over the past 52 weeks, outperforming the S&P 500 Index, which gained 13.7% during the same period [2] - Year-to-date, CBOE's stock is up 32%, compared to the S&P 500's return of 13.4% [2] - CBOE has also outperformed the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), which rose 13.7% over the past 52 weeks and 17.3% year-to-date [3] Earnings Performance - On October 31, CBOE's shares surged 3.7% following its Q3 earnings release, with total revenue reaching a record $1.1 billion, an 8.1% year-over-year increase [4] - Adjusted EPS for the quarter was $2.67, marking a 20.3% increase from the previous year and exceeding analyst estimates by 5.5% [4] Future Earnings Expectations - Analysts project CBOE's EPS to grow by 17.2% year-over-year to $10.09 for the current fiscal year ending in December [5] - CBOE has a mixed earnings surprise history, exceeding consensus estimates in three of the last four quarters [5] Analyst Ratings - Among 18 analysts covering CBOE, the consensus rating is a "Hold," consisting of four "Strong Buy," 11 "Hold," and three "Strong Sell" ratings [5] - Recent changes in analyst recommendations include three suggesting a "Strong Buy" and two recommending "Strong Sell" [6] - RBC Capital's Ashish Sabadra maintained a "Hold" rating with a price target of $254, while the mean price target is $256.93, and the highest target suggests a 12.5% potential upside from current levels [6]

Core Insights - IQVIA Holdings Inc. is valued at $37.6 billion and provides healthcare research services, including analytics, technology solutions, and clinical research to the life sciences industry, aimed at improving healthcare outcomes for patients [1] Performance Overview - Over the past year, IQV shares have gained 12.2%, underperforming the S&P 500 Index, which increased by nearly 13.7% [2] - In 2025, IQV's stock rose 10%, while the S&P 500 saw a 13.4% rise on a year-to-date basis [2] - Compared to the Health Care Select Sector SPDR Fund (XLV), which gained about 7% over the past year, IQV's performance is relatively better, although the ETF's 10.3% year-to-date returns outshine IQV's gains [3] Financial Results - For Q3, IQV reported an adjusted EPS of $3, exceeding Wall Street expectations of $2.96, and revenue of $4.10 billion, beating forecasts of $4.07 billion [4] - The company expects full-year adjusted EPS to be in the range of $11.85 to $11.95 and revenue between $16.2 billion and $16.3 billion [4] Analyst Expectations - Analysts project IQV's EPS to grow by 5.1% to $10.77 for the current fiscal year ending in December [5] - Among 22 analysts covering IQV, the consensus rating is a "Strong Buy," with 16 "Strong Buy" ratings, one "Moderate Buy," and five "Holds" [5] - A month ago, the bullish sentiment increased, with 15 analysts suggesting a "Strong Buy" [6] Price Targets - BMO Capital initiated coverage of IQV with an "Outperform" rating and a price target of $260, indicating a potential upside of 20.3% from current levels [6] - The mean price target is $244.38, representing a 13.1% premium to current prices, while the highest price target of $265 suggests an upside potential of 22.6% [6]

Core Insights - Steel Dynamics, Inc. (STLD) is a prominent steel producer and metal recycler with a market cap of $22.7 billion, offering products such as flat-rolled steel sheet and structural beams [1] - STLD's stock has underperformed the broader market over the past year, gaining 12.8% compared to the S&P 500 Index's 13.2% increase, but has outperformed on a year-to-date basis in 2025 with a 36.2% rise versus the S&P 500's 14.5% [2] - Compared to the VanEck Steel ETF (SLX), which gained about 16% over the past year, STLD's year-to-date performance of 34.9% is stronger [3] Financial Performance - On October 20, STLD reported Q3 results with an EPS of $2.74, exceeding Wall Street's expectation of $2.66, and revenue of $4.8 billion, surpassing forecasts of $4.7 billion [4] - For the current fiscal year ending in December, analysts project STLD's EPS to decline by 13.8% to $8.48 on a diluted basis, with a mixed earnings surprise history [5] Analyst Ratings - Among 13 analysts covering STLD, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, one "Moderate Buy," and four "Holds" [5] - A recent downgrade by UBS analyst Andrew Jones to a "Neutral" rating has set a price target of $165, indicating a potential upside of 6.2% from current levels, while the mean price target of $167.42 suggests a 7.7% premium [6]

Core Insights - Hydro One Limited reported an earnings per share (EPS) of $0.50, exceeding the estimated $0.47, but its revenue of approximately $876.2 million fell significantly short of the anticipated $2.3 billion [1][5] - The company's price-to-earnings (P/E) ratio is 25.44, indicating a positive market valuation of its earnings potential despite the revenue miss [2][5] Financial Performance - The EPS growth reflects strong operational efficiency, even with the revenue shortfall [2] - Hydro One's price-to-sales ratio is 3.65, and the enterprise value to sales ratio is 5.71, suggesting a robust market valuation relative to its sales [3] - The enterprise value to operating cash flow ratio stands at 20.49, indicating investor confidence in the company's cash-generating capabilities [3] Financial Health - The debt-to-equity ratio of 1.46 shows a balanced approach to financing, utilizing both debt and equity [4][5] - The current ratio of 0.36 suggests potential challenges in covering short-term liabilities with short-term assets [4][5] Strategic Focus - Hydro One is committed to supporting Ontario's growth through infrastructure projects, such as the St. Clair Transmission Line, aimed at enhancing power reliability and meeting increasing electricity demand [4]

Core Insights - Solventum Corporation (SOLV) is a healthcare company with a market cap of $12.8 billion, focusing on solutions in separation and purification, health information, medical solutions, medical device components, and oral care [1] Performance Overview - Over the past year, SOLV shares have gained 4.4%, underperforming the S&P 500 Index, which increased by nearly 14.5% [2] - Year-to-date (YTD) performance shows SOLV stock up 11.8%, while the S&P 500 has risen 16.5% [2] - Compared to the SPDR S&P Health Care Equipment ETF (XHE), which declined about 9.2% over the past year, SOLV's low double-digit returns on a YTD basis outshine the ETF's 5.1% losses [3] Financial Results - In Q3, SOLV reported an adjusted EPS of $1.50, exceeding Wall Street expectations of $1.43, and revenue of $2.10 billion, beating forecasts of $2.09 billion [4] - The company expects full-year adjusted EPS to be in the range of $5.98 to $6.08 [4] Analyst Expectations - For the current fiscal year ending in December, analysts expect SOLV's EPS to decline by 9.9% to $6.04 on a diluted basis [5] - SOLV has a strong earnings surprise history, beating consensus estimates in each of the last four quarters [5] - Among 15 analysts covering SOLV, the consensus rating is a "Moderate Buy," with five "Strong Buy" ratings, nine "Holds," and one "Strong Sell" [5] Recent Analyst Actions - The analyst configuration has become more bullish, with four analysts now suggesting a "Strong Buy" [6] - UBS maintained a "Neutral" rating on SOLV and raised the price target to $79, indicating a potential upside of 7% from current levels [6]

Company Overview - American Water Works Company, Inc. (AWK) is headquartered in Camden, New Jersey, providing water and wastewater services to approximately 1,700 communities across 14 states, serving around 3.5 million active customers. The company has a market capitalization of $25.3 billion and operates an extensive infrastructure including wastewater treatment plants, pipelines, wells, dams, and storage facilities [1]. Stock Performance - AWK shares have underperformed the broader market over the past year, declining by 2%, while the S&P 500 Index has increased by nearly 14.5%. Year-to-date, AWK stock is up 4.2%, compared to a 16.5% rise in the S&P 500 [2]. - Compared to the Global X Clean Water ETF (AQWA), which gained about 8.9% over the past year and 16.4% year-to-date, AWK's performance has been less favorable [3]. Q3 Financial Results - On October 29, AWK reported its Q3 results, with an EPS of $1.94, surpassing Wall Street expectations of $1.90. The company's revenue reached $1.5 billion, exceeding forecasts of $1.3 billion [4]. Earnings Expectations - For the current fiscal year ending in December, analysts expect AWK's EPS to grow by 6.3% to $5.73 on a diluted basis. The company's earnings surprise history is mixed, having beaten consensus estimates in three of the last four quarters while missing once [5]. Analyst Ratings - Among the 15 analysts covering AWK stock, the consensus rating is a "Hold," consisting of three "Strong Buy" ratings, ten "Holds," one "Moderate Sell," and one "Strong Sell" [5]. - The analyst outlook has improved slightly, with two analysts suggesting a "Moderate Sell" a month ago. On November 5, Jefferies Financial Group upgraded AWK to a "Hold" rating with a price target of $124. The mean price target of $143.91 indicates a 10.9% premium to current price levels, while the highest price target of $160 suggests an upside potential of 23.3% [6].

Core Viewpoint - Marathon Petroleum Corporation (MPC) is a leading independent refiner and transporter of petroleum products in the U.S., with a market cap of $60.2 billion [1] Performance Summary - MPC shares have outperformed the broader market over the past 52 weeks, increasing nearly 30%, while the S&P 500 Index has risen 14.6% [2] - Year-to-date, MPC shares have surged 44.6%, compared to the S&P 500's 16.6% gain [2] - In contrast, MPC has outpaced the Energy Select Sector SPDR Fund's (XLE) 3.1% decrease over the same period [3] Financial Results - On November 4, MPC shares fell 6.1% after reporting weaker-than-expected Q3 2025 adjusted EPS of $3.01, attributed to higher refining turnaround costs of $400 million and increased operating costs of $5.59 per barrel [4] - The company also faced renewable diesel losses of $56 million and lower-than-expected West Coast refining margins, compounded by downtime at the Galveston Bay refinery due to a June fire [4] Future Outlook - Analysts project MPC's adjusted EPS to grow 7% year-over-year to $10.39 for the current fiscal year ending in December 2025 [5] - The earnings surprise history is mixed, with MPC beating consensus estimates in three of the last four quarters [5] - Among 20 analysts covering the stock, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, three "Moderate Buys," and nine "Holds" [5] Analyst Ratings - Raymond James analyst Justin Jenkins lowered MPC's price target to $200 while maintaining an "Outperform" rating [6] - The stock is currently trading above the mean price target of $197.94, with a Street-high price target of $220 suggesting an 8.9% potential upside [6]

Core Insights - UPS has experienced significant underperformance compared to the broader market, with a decline of 27.8% over the past year, while the S&P 500 Index has increased by nearly 14.1% [2] - The company's Q3 results showed an adjusted EPS of $1.74, surpassing Wall Street expectations of $1.31, and revenue of $21.4 billion, exceeding forecasts of $20.8 billion [4] - Analysts predict a 10.9% decline in UPS' EPS for the current fiscal year, with a consensus rating of "Moderate Buy" among 31 analysts [5] Performance Comparison - UPS has lagged behind the Pacer Industrials and Logistics ETF, which gained about 3.1% over the past year, while UPS stock has seen double-digit losses [3] - Year-to-date, UPS stock is down 24.6%, contrasting with a 16.4% increase in the S&P 500 [2] Analyst Ratings and Price Targets - The current analyst configuration shows a decrease in bullish sentiment compared to two months ago, with only 13 "Strong Buy" ratings among the 31 analysts [5][6] - Truist Financial Corporation has maintained a "Buy" rating on UPS and raised the price target to $120, indicating a potential upside of 26.3% from current levels [6] - The mean price target of $104.10 suggests a 9.5% premium to UPS' current price, while the highest price target of $122 indicates an upside potential of 28.4% [6]

Core Insights - Primoris Services Corporation (PRIM) is experiencing strong demand across various sectors, including power delivery, gas operations, communications, renewable energy, and industrial markets, driven by increased public infrastructure spending [2][3] - The company reported adjusted earnings per share (EPS) of $1.88 for Q3 2025, a 54.1% increase from $1.22 in the same quarter last year, supported by revenue growth and reduced expenses [3][8] - The One Big Beautiful Bill Act is positively impacting market trends by providing tax incentives and allocating $150 billion for defense spending, which is expected to enhance project backlogs for PRIM [3][4] Financial Performance - PRIM's consolidated revenues grew by 32.1% year over year in Q3 2025, while interest expenses decreased by 61.1% and SG&A expenses fell by 0.4% due to effective cost control measures [3][4] - The adjusted EPS outlook for 2025 has been raised to a range of $5.35-$5.55, up from the previous estimate of $4.90-$5.10, indicating confidence in sustained growth [4][8] - The Zacks Consensus Estimate indicates year-over-year earnings growth of 31.3% for 2025 and 9.3% for 2026, reflecting the company's strong market position [5][6] Market Position - PRIM's stock has increased by 12.6% over the past three months, outperforming competitors in the heavy construction industry and the broader S&P 500 index [7][8] - Competitors such as MasTec, Inc. (MTZ) and Jacobs Solutions Inc. (J) have also seen stock gains of 9.1% and 3%, respectively, indicating a competitive landscape in the public infrastructure sector [10] - PRIM is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 23.51, which is a premium compared to its peers [11][12]